| scholarly article | Q13442814 |
| P2093 | author name string | William M Baldwin | |
| John V Conte | |||
| Andrea A Zachary | |||
| Carmela D Tan | |||
| E R Rodriguez | |||
| Edward K Kasper | |||
| Diane V Skojec | |||
| P2860 | cites work | Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications | Q69566131 |
| Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients | Q72183817 | ||
| Reliability and usefulness of immunofluorescence in heart transplantation | Q72183821 | ||
| Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies | Q73100253 | ||
| Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection | Q73231144 | ||
| Role of antibodies in transplant-associated cardiac allograft vasculopathy | Q73382621 | ||
| C4d and the fate of organ allografts | Q74644341 | ||
| Diffuse C4d deposition and morphology of acute humoral rejection in a stable renal allograft | Q79162277 | ||
| Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation | Q79369493 | ||
| Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies: comparison to frozen tissue immunofluorescence | Q80539992 | ||
| The pathology of heart transplant biopsy specimens: revisiting the 1990 ISHLT working formulation | Q35047064 | ||
| Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection | Q35666593 | ||
| Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection | Q36017741 | ||
| Chronic allograft nephropathy | Q36094077 | ||
| Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation | Q38333120 | ||
| Activation of intravascular macrophages within myocardial small vessels is a feature of acute vascular rejection in human heart transplants | Q40544098 | ||
| Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes | Q40794415 | ||
| Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. | Q43931517 | ||
| Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match | Q44101443 | ||
| Role of caveolin-1 and cytoskeletal proteins, actin and vimentin, in adipogenesis of bovine intramuscular preadipocyte cells | Q45046175 | ||
| Antithymocyte globulin is associated with complement deposition in cardiac transplant biopsies | Q45158303 | ||
| Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. | Q46126109 | ||
| National conference to assess antibody-mediated rejection in solid organ transplantation | Q47347260 | ||
| Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets: I. Evaluation of the GTI QuikID assay and analysis of antibody patterns | Q47634524 | ||
| Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers | Q47947404 | ||
| Acute vascular humoral rejection in a sensitized cardiac graft recipient: diagnostic value of C4d immunofluorescence | Q47960755 | ||
| A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. | Q50703115 | ||
| Incidence of C4d Stain in Protocol Biopsies from Renal Allografts: Results from a Multicenter Trial | Q58378349 | ||
| Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies | Q68064229 | ||
| Acute humoral rejection: a new entity in the histopathology of heart transplantation | Q68915850 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 2778-2785 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers | |
| P478 | volume | 5 |
| Q39993576 | A web-based pilot study of inter-pathologist reproducibility using the ISHLT 2004 working formulation for biopsy diagnosis of cardiac allograft rejection: the European experience |
| Q33852943 | Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury |
| Q40108113 | Acute Cellular Rejection and C4d Positivity in Heart Transplantation : A Manifestation of Asymptomatic Antibody-Mediated Rejection? |
| Q36872090 | Acute antibody-mediated rejection following heart transplantation |
| Q36491797 | Acute rejection after heart transplantation. |
| Q26766411 | Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen |
| Q37445163 | Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts |
| Q35611613 | Antibody to human leukocyte antigen triggers endothelial exocytosis |
| Q37969113 | Antibody-mediated rejection in heart transplantation: case presentation with a review of current international guidelines |
| Q35876250 | Antibody-mediated rejection: an evolving entity in heart transplantation |
| Q37313068 | Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. |
| Q84556573 | C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts |
| Q50899566 | C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. |
| Q37778272 | Cardiac allograft vasculopathy: do adipocytes bridge alloimmune and metabolic risk factors? |
| Q38002449 | Cardiac antibody-mediated rejection |
| Q37256207 | Chemokines and transplant vasculopathy |
| Q51770229 | Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. |
| Q34821994 | Coincidence of cellular and antibody mediated rejection in heart transplant recipients - preliminary report |
| Q35655757 | Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice |
| Q37794631 | Diagnosis of antibody-mediated rejection in cardiac transplantation: a call for standardization |
| Q42738129 | Dimensions of antibody-mediated rejection |
| Q54488322 | Does asymptomatic recurrent diffuse capillary C4d complement deposition impair cardiac allograft function? |
| Q38103486 | Endothelium and regulatory inflammatory mechanisms during organ rejection. |
| Q38934309 | Heart transplant recipient with history of Chagas disease and elevated panel-reactive antibodies |
| Q44274789 | Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients |
| Q88867248 | Immune Checkpoint Inhibitor-Associated Myocarditis |
| Q34289043 | Immunological challenges of cardiac transplantation: the need for better animal models to answer current clinical questions |
| Q28749508 | Management of allosensitized cardiac transplant candidates |
| Q37966118 | Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies |
| Q24629268 | Mechanisms involved in antibody- and complement-mediated allograft rejection |
| Q37441972 | Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection |
| Q36274176 | New concepts of complement in allorecognition and graft rejection |
| Q104748205 | Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection |
| Q37426021 | Pathologic findings in lung allografts with anti-HLA antibodies |
| Q38645385 | Potential Roles for C1 Inhibitor in Transplantation |
| Q37313051 | Report from a consensus conference on antibody-mediated rejection in heart transplantation |
| Q38168615 | Rituximab is associated with improved survival in cardiac allograft patients with antibody-mediated rejection: a single center review. |
| Q42138480 | Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection |
| Q37729059 | Role of T cells in graft rejection and transplantation tolerance. |
| Q51043732 | Sequential analysis of donor-specific antibodies and pathological findings in acute antibody-mediated rejection in a rat renal transplantation model. |
| Q46947691 | Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts |
| Q50986928 | Successful management of antibody-mediated rejection after cardiac transplantation in a patient supported by a left ventricular assist device for more than 3 years. |
| Q28087773 | The Complement System and Antibody-Mediated Transplant Rejection |
| Q89148849 | Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients |
| Q36488525 | Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation |
| Q83179025 | [Current status of heart transplantation in Spain] |
Search more.